Avecho Biotechnology Limited (OEZ) — Financial Flexibility Index
Avecho Biotechnology Limited (OEZ) has a Financial Flexibility Index of -0.88x as of December 2022. Free cash flow of €-806.30K (operating CF €-808.80K minus capex €2.50K) represents -1% of total liabilities (€920.66K). Check OEZ capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avecho Biotechnology Limited Financial Flexibility Index (2013–2022)
Historical Financial Flexibility Index trend for Avecho Biotechnology Limited across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Avecho Biotechnology Limited generate cash.
Annual Financial Flexibility Index for Avecho Biotechnology Limited (2013–2022)
Year-by-year free cash flow to debt coverage for Avecho Biotechnology Limited. Explore cash flow to debt ratio of Avecho Biotechnology Limited to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.75x | €-1.61 Million | €-1.67 Million | €920.66K | ▲ +57.1% |
| 2021 | -4.08x | €-2.90 Million | €-3.10 Million | €709.36K | ▼ -101.5% |
| 2020 | -2.03x | €-1.42 Million | €-1.42 Million | €700.17K | ▼ -195.3% |
| 2019 | 2.13x | €1.18 Million | €1.18 Million | €556.12K | ▲ +187.7% |
| 2018 | -2.42x | €-2.19 Million | €-2.19 Million | €902.04K | ▲ +30.1% |
| 2017 | -3.47x | €-6.37 Million | €-6.42 Million | €1.84 Million | ▲ +6.8% |
| 2016 | -3.72x | €-6.35 Million | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.74x | €-8.62 Million | €-8.71 Million | €1.82 Million | ▼ -33.8% |
| 2014 | -3.55x | €-6.64 Million | €-6.74 Million | €1.87 Million | ▲ +8.1% |
| 2013 | -3.86x | €-8.45 Million | €-8.58 Million | €2.19 Million | — |